These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 8818193)
1. Effect of 1,24-dihydroxyvitamin D3 on proliferation stimulated by epidermal growth factor in cultured mouse epidermal keratinocytes. Ohta T; Mimura H; Kiyoki M Arch Dermatol Res; 1996 Jun; 288(7):415-7. PubMed ID: 8818193 [No Abstract] [Full Text] [Related]
2. [Distribution of DNA-synthesizing cells in migrating colonies of human epidermal keratinocytes]. Voroteliak EA; Satdykova GP; Samarova AV; Vasil'ev AV; Danilova TI; Terskikh VV Dokl Akad Nauk; 1997 Jun; 354(6):829-31. PubMed ID: 9289288 [No Abstract] [Full Text] [Related]
3. 1 alpha,24R-dihydroxyvitamin D3 has an ability comparable to that of 1 alpha,25-dihydroxyvitamin D3 to induce keratinocyte differentiation. Kobayashi T; Okumura H; Azuma Y; Kiyoki M; Matsumoto K; Hashimoto K; Yoshikawa K J Dermatol; 1990 Nov; 17(11):707-9. PubMed ID: 2094749 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of ornithine decarboxylase activity and cell proliferation by ultraviolet B radiation in EGF-stimulated cultured human epidermal keratinocytes. Prystowsky JH; Clevenger CV; Zheng ZS J Invest Dermatol; 1993 Jul; 101(1):54-8. PubMed ID: 8331297 [TBL] [Abstract][Full Text] [Related]
5. Tacalcitol, an active vitamin D3, induces nerve growth factor production in human epidermal keratinocytes. Fukuoka M; Sakurai K; Ohta T; Kiyoki M; Katayama I Skin Pharmacol Appl Skin Physiol; 2001; 14(4):226-33. PubMed ID: 11464105 [TBL] [Abstract][Full Text] [Related]
6. Effect of 1,24R-dihydroxyvitamin D3 on the growth of human keratinocytes. Matsumoto K; Hashimoto K; Kiyoki M; Yamamoto M; Yoshikawa K J Dermatol; 1990 Feb; 17(2):97-103. PubMed ID: 2158504 [TBL] [Abstract][Full Text] [Related]
7. 1,24(R)-dihydroxyvitamin D3, a novel active form of vitamin D3 with high activity for inducing epidermal differentiation but decreased hypercalcemic activity. Matsunaga T; Yamamoto M; Mimura H; Ohta T; Kiyoki M; Ohba T; Naruchi T; Hosoi J; Kuroki T J Dermatol; 1990 Mar; 17(3):135-42. PubMed ID: 2162363 [TBL] [Abstract][Full Text] [Related]
9. Modulation of human epidermal cell response to 2,3,7,8-tetrachlorodibenzo-p-dioxin by epidermal growth factor. Rea MA; Phillips MA; Degraffenried LA; Qin Q; Rice RH Carcinogenesis; 1998 Mar; 19(3):479-83. PubMed ID: 9525283 [TBL] [Abstract][Full Text] [Related]
10. Inhibitory action of epiderstatin on EGF-stimulated growth of mouse epidermal. BALB/MK cells without direct effect on protein kinase activities. Osada H; Kikuchi K; Makishima F; Isono K Oncol Res; 1994; 6(1):11-7. PubMed ID: 7919547 [TBL] [Abstract][Full Text] [Related]
11. Stimulation of thymidine incorporation in keratinocytes by insulin, epidermal growth factor, and placental extract: comparison with cell number to assess growth. O'Keefe EJ; Chiu ML J Invest Dermatol; 1988 Jan; 90(1):2-7. PubMed ID: 2447191 [TBL] [Abstract][Full Text] [Related]
12. Human EGF receptor (HER) family and heregulin members are differentially expressed in epidermal keratinocytes and modulate differentiation. De Potter IY; Poumay Y; Squillace KA; Pittelkow MR Exp Cell Res; 2001 Dec; 271(2):315-28. PubMed ID: 11716544 [TBL] [Abstract][Full Text] [Related]
13. [The modelling of in-vitro epidermal regeneration: the joint action of serum and epidermal growth factor]. Vasil'ev AV; Voroteliak EA; Terskikh VV Ontogenez; 1994; 25(3):74-9. PubMed ID: 8047333 [TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor and temperature regulate keratinocyte differentiation. Ponec M; Gibbs S; Weerheim A; Kempenaar J; Mulder A; Mommaas AM Arch Dermatol Res; 1997 May; 289(6):317-26. PubMed ID: 9209676 [TBL] [Abstract][Full Text] [Related]
15. The receptor tyrosine kinase ERBB4 is expressed in skin keratinocytes and influences epidermal proliferation. Hoesl C; Röhrl JM; Schneider MR; Dahlhoff M Biochim Biophys Acta Gen Subj; 2018 Apr; 1862(4):958-966. PubMed ID: 29410073 [TBL] [Abstract][Full Text] [Related]
17. Topical treatment of psoriatic plaques with 1 alpha, 24 dihydroxyvitamin D3: a multiparameter flow cytometrical analysis of epidermal growth, differentiation and inflammation. Glade CP; van Erp PE; van Hooijdonk CA; Elbers ME; van de Kerkhof PC Acta Derm Venereol; 1995 Sep; 75(5):381-5. PubMed ID: 8615058 [TBL] [Abstract][Full Text] [Related]
18. Placental keratinocyte growth factor: partial purification and comparison with epidermal growth factor. Chiu ML; O'Keefe EJ Arch Biochem Biophys; 1989 Feb; 269(1):75-85. PubMed ID: 2783841 [TBL] [Abstract][Full Text] [Related]
19. Heparin-binding epidermal-growth-factor-like growth factor activation of keratinocyte ErbB receptors Mediates epidermal hyperplasia, a prominent side-effect of retinoid therapy. Varani J; Zeigler M; Dame MK; Kang S; Fisher GJ; Voorhees JJ; Stoll SW; Elder JT J Invest Dermatol; 2001 Dec; 117(6):1335-41. PubMed ID: 11886492 [TBL] [Abstract][Full Text] [Related]
20. RANTES expression in psoriatic skin, and regulation of RANTES and IL-8 production in cultured epidermal keratinocytes by active vitamin D3 (tacalcitol). Fukuoka M; Ogino Y; Sato H; Ohta T; Komoriya K; Nishioka K; Katayama I Br J Dermatol; 1998 Jan; 138(1):63-70. PubMed ID: 9536224 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]